Discontinuation report TIGECYCLINE
| Report ID | 87218 |
| Drug Identification Number | 02409356 |
| Brand name | TIGECYCLINE |
| Common or Proper name | TIGECYCLINE |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TIGECYCLINE |
| Strength(s) | 50MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 5ML VIAL |
| ATC code | J01AA |
| ATC description | TETRACYCLINES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2020-01-01 |
| Actual discontinuation date | |
| Remaining supply date | 2020-01-01 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Limited inventory is availble |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2019-06-21 | French | Compare |
| v1 | 2019-06-21 | English | Compare |
Showing 1 to 2 of 2